Comparative assessment of the HAS-BLED score with other published bleeding risk scoring schemes, for intracranial haemorrhage risk in a non-atrial fibrillation population: The Chin-Shan Community Cohort Study-Reference-Cited by-同舟云学术

Comparative assessment of the HAS-BLED score with other published bleeding risk scoring schemes, for intracranial haemorrhage risk in a non-atrial fibrillation population: The Chin-Shan Community Cohort Study

Published:2013-10 Issue:3 Volume:168 Page:1832-1836
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Lip Gregory Y.H.,Lin Hung-Ju,Hsu Hsiu-Ching,Su Ta-Chen,Chen Ming-Fong,Lee Yuan-Teh,Chien Kuo-Liong

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference29 articles.

1. Bleeding risk assessment and management in atrial fibrillation patients. Executive Summary of a Position Document from the European Heart Rhythm Association [EHRA], endorsed by the European Society of Cardiology [ESC] Working Group on Thrombosis;Lip;Thromb Haemost,2011

2. A novel user-friendly score (HAS-BLED) to assess one year risk of major bleeding in atrial fibrillation patients: The Euro Heart Survey;Pisters;Chest,2010

3. Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation

4. Bleeding risk in ‘real world’ patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort;Olesen;J Thromb Haemost,2011

5. Evaluation of risk stratification schemes for ischemic stroke and bleeding in 182,678 patients with atrial fibrillation: The Swedish Atrial Fibrillation cohort study;Friberg;Eur Heart J,2012

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment and Mitigation of Bleeding Risk in Atrial Fibrillation and Venous Thromboembolism: Executive Summary of a European and Asia-Pacific Expert Consensus Paper;Thrombosis and Haemostasis;2022-07-06

2. Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis, in collaboration with the European Heart Rhythm Association, the Association for Acute CardioVascular Care and the Asia-Pacific Heart Rhythm Society;EP Europace;2022-03-22

3. Empiric use of anticoagulation in hospitalized patients with COVID-19: a propensity score-matched study of risks and benefits;Biomarker Research;2021-05-01

4. Neurological complications of cardiovascular drugs;Handbook of Clinical Neurology;2021

5. Risk factors for severe bleeding events during warfarin treatment: the influence of sex, age, comorbidity and co-medication;European Journal of Clinical Pharmacology;2020-03-28